TrivarX Limited (AU:TRI)
ASX:TRI
TRI Stock Chart & Stats
AU$0.02
<AU$0.01(6.67%)
At close: 4:00 PM EST
AU$0.02
<AU$0.01(6.67%)
Day’s Range― - ―
52-Week Range<AU$0.01 - AU$0.04
Previous CloseN/A
Volume87.40K
Average Volume (3M)1.22M
Market Cap
AU$21.92M
Enterprise ValueAU$20.84M
Total Cash (Recent Filing)AU$1.25M
Total Debt (Recent Filing)AU$169.03K
Price to Earnings (P/E)―
Beta2.78
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,153,693,500
10 Day Avg. Volume1,871,965
30 Day Avg. Volume1,217,195
Financial Highlights & Ratios
PEG Ratio0.23
Price to Book (P/B)0.82
Price to Sales (P/S)0.00
P/FCF Ratio-54.76
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetVery low debt and a meaningful equity base materially reduce financial distress risk. This durable capital cushion gives management runway to fund development, weather losses, and pursue strategic options without immediate reliance on expensive debt, supporting long-term viability.
Sharp Reduction In Cash BurnA large year-over-year improvement in free cash flow signals effective cost control and operational progress. Sustained lower cash burn extends runway, reduces near-term financing needs, and increases the probability the company reaches self-funding if the trend continues over the next several quarters.
Improving Profitability TrendSequential improvement in net losses suggests management is narrowing the gap to profitability. If underlying revenue or commercialization activity begins, this trend implies operating leverage could convert modest revenue into positive margins over time, a durable operational positive.
Bears Say
No Reported RevenueZero reported revenue limits visibility into product-market fit and undermines the firm's ability to demonstrate scalable demand or gross margin profile. Without proven sales, the business remains highly dependent on financing and uncertain in its path to sustainable, repeatable cash generation.
Negative Cash GenerationContinued negative operating and free cash flow means the company is not self-funding and must secure external capital to sustain operations. Over months this constrains investment in commercialisation and increases dilution or refinancing risk, a persistent structural weakness until cash flow turns positive.
Negative Return On EquityA negative ROE shows deployed equity capital is not producing returns, signaling inefficient use of shareholder funds. If persistent, this erodes investor value and indicates deeper operational or market adoption problems that must be addressed to justify the equity base long term.
TrivarX Limited News
TRI FAQ
What was TrivarX Limited’s price range in the past 12 months?
TrivarX Limited lowest share price was <AU$0.01 and its highest was AU$0.04 in the past 12 months.
What is TrivarX Limited’s market cap?
TrivarX Limited’s market cap is AU$21.92M.
When is TrivarX Limited’s upcoming earnings report date?
TrivarX Limited’s upcoming earnings report date is Aug 27, 2026 which is in 151 days.
How were TrivarX Limited’s earnings last quarter?
TrivarX Limited released its earnings results on Feb 24, 2026. The company reported -AU$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.002.
Is TrivarX Limited overvalued?
According to Wall Street analysts TrivarX Limited’s price is currently Overvalued.
Does TrivarX Limited pay dividends?
TrivarX Limited does not currently pay dividends.
What is TrivarX Limited’s EPS estimate?
TrivarX Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does TrivarX Limited have?
TrivarX Limited has 1,153,693,500 shares outstanding.
What happened to TrivarX Limited’s price movement after its last earnings report?
TrivarX Limited reported an EPS of -AU$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -8.696%.
Which hedge fund is a major shareholder of TrivarX Limited?
Currently, no hedge funds are holding shares in AU:TRI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
TrivarX Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
-7.84%
Trailing 12-Months
Asset Growth
112.47%
Trailing 12-Months
Company Description
TrivarX Limited
TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023. TrivarX Limited was incorporated in 1987 and is based in Mount Lawley, Australia.
Technical Analysis
Tali Digital
―
Global Health Limited
―
Opyl Ltd.
―
HitIQ Limited
―
InteliCare Holdings Limited
―
Options Prices
Currently, No data available
---